FDA considers more rigorous enforcement for homeopathic products over safety risks: New labeling is possible; pre-market testing seems unlikely

摘要

After decades of delay, the Food and Drug Administration (FDA) is apparently getting around to considering again whether to subject homeopathic medicines to a higher regulatory standard. Most of those products are sold over the counter (OTC) and can be referred to as nutraceuticals, dietary supplements, and herbal products, although there is some disagreement as to whether herbals are part of the category.